Hercules Capital Quarterly Balance Sheets Chart
Quarterly
|
Annual
Hercules Capital Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2024-12-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2011-03-31 | 2010-06-30 | 2010-03-31 | 2009-09-30 | 2009-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||||||||||||||||
| investments, at fair value: | ||||||||||||||||||||||||||||||||||||||
| non-control/non-affiliate investments | 3,546,799,000 | 3,457,280,000 | 3,459,426,000 | 3,133,042,000 | 3,133,042,000 | 2,385,998,000 | 2,288,338 | 2,355,935,000 | 2,297,180,000 | 2,238,479,000 | 2,232,972 | 2,167,682,000 | 2,174,691,000 | 2,003,062,000 | 1,801,258,000 | 1,670,034,000 | 1,616,515,000 | 1,398,640,000 | 1,491,458 | 1,360,146,000 | 1,357,914,000 | 1,376,181,000 | 1,414,210 | 1,309,696,000 | 1,292,934,000 | 1,142,544,000 | 1,228,202,000 | 1,150,639,000 | 1,012,738 | 990,068,000 | 983,952,000 | 443,022,000 | 390,399,000 | 332,728,000 | ||||
| control investments | 113,179,000 | 111,259,000 | 112,215,000 | 115,004,000 | 115,004,000 | 68,693,000 | 57,400 | 55,092,000 | 54,431,000 | 51,775,000 | 59,746 | 58,560,000 | 55,894,000 | 54,913,000 | 57,619,000 | 62,387,000 | 56,716,000 | 54,413,000 | 19,461 | 23,382,000 | 31,564,000 | 24,775,000 | 4,700 | 4,991,000 | 4,000,000 | 37,904,000 | 45,023,000 | |||||||||||
| total investments, at fair value | 3,659,978,000 | 3,568,539,000 | 3,571,641,000 | 3,248,046,000 | 3,248,046,000 | 2,464,355,000 | 2,354,078 | |||||||||||||||||||||||||||||||
| cash and cash equivalents | 42,679,000 | 27,676,000 | 50,176,000 | 98,899,000 | 98,899,000 | 74,987,000 | 198,282 | 27,554,000 | 35,884,000 | 34,282,000 | 64,393 | 21,045,000 | 13,261,000 | 16,465,000 | 34,212,000 | 43,212,000 | 59,461,000 | 118,228,000 | 91,309 | 140,568,000 | 160,412,000 | 148,140,000 | 13,044 | 69,012,000 | 59,715,000 | 13,478,000 | 95,196 | 147,304,000 | 115,987,000 | 171,756,000 | 227,116 | 158,627,000 | 116,008,000 | 114,435,000 | 52,751,000 | 106,138,000 | 77,247,000 | 37,367,000 |
| foreign cash | 70,445,000 | |||||||||||||||||||||||||||||||||||||
| restricted cash | 3,297,000 | 11,242,000 | 10,110,000 | 17,114,000 | 17,114,000 | 11,829,000 | 39,340 | 20,507,000 | 33,599,000 | 22,060,000 | 50,603 | 14,886,000 | 15,339,000 | 10,149,000 | 11,645,000 | 2,429,000 | 15,886,000 | 3,632,000 | 3,686 | 7,813,000 | 17,226,000 | 12,924,000 | 8,322 | 8,980,000 | 3,605,000 | 3,646,000 | 9,191 | 5,358,000 | 11,810,000 | 21,949,000 | 12,660 | 2,096,000 | 3,491,000 | |||||
| interest receivable | 32,578,000 | 31,533,000 | 35,399,000 | 32,741,000 | 32,741,000 | 20,597,000 | 19,077 | 19,506,000 | 19,458,000 | 19,137,000 | 20,207 | 19,847,000 | 18,206,000 | 18,366,000 | 16,959,000 | 15,722,000 | 14,408,000 | 11,087,000 | 12,262 | 10,507,000 | 10,204,000 | 11,484,000 | 11,614 | 10,861,000 | 9,453,000 | 10,993,000 | 9,239 | 8,528,000 | 9,226,000 | 9,102,000 | 9,453 | 9,146,000 | 8,700,000 | 4,306,000 | 11,114,000 | 11,369,000 | 10,382,000 | 9,327,000 |
| right of use asset | 16,778,000 | 18,104,000 | 18,579,000 | 4,787,000 | 4,787,000 | 8,666,000 | 9,278 | 9,884,000 | 10,492,000 | 11,078,000 | 11,659 | 12,218,000 | 8,493,000 | 8,856,000 | ||||||||||||||||||||||||
| other assets | 5,836,000 | 15,042,000 | 10,128,000 | 15,339,000 | 15,339,000 | 3,417,000 | 3,942 | 5,723,000 | 5,547,000 | 7,714,000 | 580 | 1,727,000 | 4,269,000 | 3,753,000 | 2,002,000 | 1,175,000 | 906,000 | 3,187,000 | 5,244 | 6,995,000 | 5,398,000 | 7,433,000 | 7,282 | 9,961,000 | 19,620,000 | 12,388,000 | 20,497 | 19,813,000 | 20,875,000 | 22,860,000 | 29,257 | 30,556,000 | 29,929,000 | 10,611,000 | 6,948,000 | 6,687,000 | 5,851,000 | 7,085,000 |
| total assets | 3,831,591,000 | 3,672,136,000 | 3,696,033,000 | 3,416,926,000 | 3,416,926,000 | 2,583,851,000 | 2,623,997 | 2,504,001,000 | 2,468,501,000 | 2,396,751,000 | 2,461,968 | 2,316,929,000 | 2,311,567,000 | 2,138,631,000 | 1,945,191,000 | 1,823,054,000 | 1,792,597,000 | 1,619,712,000 | 1,654,715 | 1,582,997,000 | 1,588,709,000 | 1,586,248,000 | 1,464,204 | 1,419,424,000 | 1,395,171,000 | 1,331,815,000 | 1,334,761 | 1,332,731,000 | 1,396,553,000 | 1,387,088,000 | 1,299,223 | 1,199,338,000 | 1,149,473,000 | 574,406,000 | 497,441,000 | 500,957,000 | 505,120,000 | 501,895,000 |
| liabilities | ||||||||||||||||||||||||||||||||||||||
| debt | 1,768,955,000 | 1,747,127,000 | 1,751,998,000 | 1,554,869,000 | 1,554,869,000 | 1,231,298,000 | ||||||||||||||||||||||||||||||||
| accounts payable and accrued liabilities | 54,861,000 | 49,519,000 | 38,698,000 | 54,156,000 | 54,156,000 | 28,300,000 | 36,343 | 28,782,000 | 29,162,000 | 22,450,000 | 30,306 | 25,451,000 | 27,274,000 | 18,256,000 | 25,961,000 | 21,473,000 | 25,115,000 | 18,789,000 | 26,896 | 19,057,000 | 22,193,000 | 16,513,000 | 21,463 | 16,649,000 | 16,681,000 | 12,086,000 | 17,241 | 19,613,000 | 12,977,000 | 9,320,000 | 14,101 | 11,613,000 | 10,393,000 | 7,449,000 | 7,658,000 | 3,945,000 | 5,798,000 | 6,645,000 |
| operating lease liability | 18,194,000 | 18,945,000 | 19,399,000 | 5,195,000 | 5,195,000 | 8,859,000 | 9,312 | 9,753,000 | 10,178,000 | 11,144,000 | 11,538 | 11,922,000 | 8,530,000 | 8,856,000 | ||||||||||||||||||||||||
| total liabilities | 1,842,010,000 | 1,815,591,000 | 1,810,095,000 | 1,614,220,000 | 1,614,220,000 | 1,268,457,000 | 1,332,293 | 1,330,921,000 | 1,304,471,000 | 1,299,671,000 | 1,328,919 | 1,231,248,000 | 1,206,883,000 | 1,148,282,000 | 989,747,000 | 818,874,000 | 828,900,000 | 790,981,000 | 813,748 | 746,713,000 | 771,258,000 | 778,352,000 | 676,260 | 665,835,000 | 677,376,000 | 613,435,000 | 617,627 | 609,938,000 | 652,862,000 | 623,762,000 | 640,359 | 543,140,000 | 490,564,000 | 171,199,000 | 144,758,000 | 134,545,000 | 136,398,000 | 137,662,000 |
| commitments and contingencies | ||||||||||||||||||||||||||||||||||||||
| net assets consist of: | ||||||||||||||||||||||||||||||||||||||
| common stock | 171,000 | 163,000 | 163,000 | 158,000 | 158,000 | 116,000 | 115 | 115,000 | 115,000 | 111,000 | 108 | 105,000 | 104,000 | 96,000 | 96,000 | 96,000 | 94,000 | 85,000 | 85 | 84,000 | 83,000 | 83,000 | 80 | 77,000 | 75,000 | 74,000 | 73 | 73,000 | 73,000 | 73,000 | 65 | 65,000 | 64,000 | 43,000 | 36,000 | 35,000 | 35,000 | 35,000 |
| capital in excess of par value | 1,900,490,000 | 1,737,478,000 | 1,730,829,000 | 1,662,535,000 | 1,662,535,000 | 1,160,519,000 | 1,158,198 | 1,225,823,000 | 1,223,263,000 | 1,182,080,000 | 1,145,106 | 1,147,054,000 | 1,149,774,000 | 1,051,427,000 | 1,052,269,000 | 1,060,875,000 | 1,026,313,000 | 916,738,000 | 908,501 | 904,357,000 | 892,930,000 | 890,861,000 | 839,657 | 802,521,000 | 774,339,000 | 761,565,000 | 752,244 | 757,646,000 | 760,148,000 | 760,034,000 | 657,233 | 670,711,000 | 668,673,000 | 478,959,000 | 408,502,000 | 410,349,000 | 408,733,000 | 407,300,000 |
| total distributable earnings | 88,920,000 | 118,904,000 | 154,946,000 | 140,013,000 | 140,013,000 | 154,759,000 | 133,391 | -52,858,000 | -59,348,000 | -85,111,000 | -12,165 | -61,478,000 | -45,194,000 | -61,174,000 | -92,859,000 | |||||||||||||||||||||||
| total net assets | 1,989,581,000 | 1,856,545,000 | 1,885,938,000 | 1,802,706,000 | 1,802,706,000 | 1,315,394,000 | 1,291,704 | 1,173,080,000 | 1,164,030,000 | 1,097,080,000 | 1,133,049 | 1,085,681,000 | 1,104,684,000 | 990,349,000 | 955,444,000 | 1,004,180,000 | 963,697,000 | 828,731,000 | 840,967 | 836,284,000 | 817,451,000 | 807,896,000 | 787,944 | 753,589,000 | 717,795,000 | 718,380,000 | 717,134 | 722,793,000 | 743,691,000 | 763,326,000 | 658,864 | 656,198,000 | 658,909,000 | 403,207,000 | 352,683,000 | 366,412,000 | 368,722,000 | 364,233,000 |
| total liabilities and net assets | 3,831,591,000 | 3,672,136,000 | 3,696,033,000 | 3,416,926,000 | 3,416,926,000 | 2,583,851,000 | 2,623,997 | 2,504,001,000 | 2,468,501,000 | 2,396,751,000 | 2,461,968 | 2,316,929,000 | 2,311,567,000 | 2,138,631,000 | 1,945,191,000 | 1,823,054,000 | 1,792,597,000 | 1,619,712,000 | 1,654,715 | 1,582,997,000 | 1,588,709,000 | 1,586,248,000 | 1,464,204 | 1,419,424,000 | 1,395,171,000 | 1,331,815,000 | 1,334,761 | 1,332,731,000 | 1,396,553,000 | 1,387,088,000 | 1,299,223 | 1,199,338,000 | 1,149,473,000 | 574,406,000 | ||||
| shares of common stock outstanding | 170,575,000 | 162,428,000 | 162,230,000 | 157,758,000 | 157,758,000 | 115,768,000 | 114,726 | 114,317,000 | 114,230,000 | 110,601,000 | 107,364 | 104,636,000 | 104,282,000 | 96,543,000 | 96,501,000 | 96,751,000 | 94,260,000 | 85,239,000 | 84,424 | 83,615,000 | 82,819,000 | 82,801,000 | 79,555 | 76,400,000 | 74,320,000 | 73,230,000 | 72,118 | 72,109,000 | 72,493,000 | 72,891,000 | 64,715 | 64,182,000 | 63,251,000 | 43,804,000 | 35,972,000 | 36,248,000 | 35,546,000 | 35,452,000 |
| net asset value per share | 11,660 | 11,430 | 11,630 | 11,430 | 11,430 | 11,360 | 11.26 | 10,260 | 10,190 | 9,920 | 10.55 | 10,380 | 10,590 | 10,260 | 9,900 | 10,380 | 10,220 | 9,720 | 9.96 | 10,000 | 9,870 | 9,760 | 9.9 | 9,860 | 9,660 | 9,810 | 9.94 | 10,020 | 10,260 | 10,470 | 10.18 | 10,220 | 10,420 | 9,200 | 9,800 | 10,110 | 10,370 | 10,270 |
| affiliate investments | 9,664,000 | 8,340 | 9,800,000 | 11,910,000 | 12,226,000 | 21,808 | 20,964,000 | 21,414,000 | 23,067,000 | 21,496,000 | 28,095,000 | 28,705,000 | 30,525,000 | 31,295 | 33,586,000 | 5,991,000 | 5,311,000 | 5,032 | 5,923,000 | 5,844,000 | 9,184,000 | 10,453,000 | 10,782,000 | 7,999 | 8,845,000 | 7,393,000 | 2,032,000 | 3,218,000 | 2,222,000 | 4,280,000 | 1,133,000 | |||||||
| 2027 asset-backed notes, investments in securities, at value | 235,476,000 | |||||||||||||||||||||||||||||||||||||
| 2028 asset-backed notes, investments in securities, at value | 340,620,000 | |||||||||||||||||||||||||||||||||||||
| 2027 asset-backed notes | 130,016,000 | 178,812 | 197,521,000 | 197,448,000 | 197,377,000 | 197,312 | 197,241,000 | 197,171,000 | 197,102,000 | 197,265,000 | ||||||||||||||||||||||||||||
| 2028 asset-backed notes | 219,413,000 | 247,647 | 247,579,000 | 247,511,000 | 247,444,000 | 247,395 | 247,333,000 | 247,266,000 | 247,352,000 | |||||||||||||||||||||||||||||
| sba debentures | 98,716 | 98,668,000 | 109,808,000 | 109,725,000 | 148,165 | 148,038,000 | 147,910,000 | 147,783,000 | 147,655,000 | 147,527,000 | 188,457,000 | 188,299,000 | 188,141 | 187,983,000 | 187,824,000 | 187,669,000 | ||||||||||||||||||||||
| 2022 notes | 149,039 | 148,907,000 | 148,776,000 | 148,645,000 | 148,514 | 148,383,000 | 148,252,000 | 148,121,000 | 147,990,000 | 147,859,000 | 147,728,000 | 147,698,000 | 147,572 | |||||||||||||||||||||||||
| july 2024 notes | 103,942 | 103,869,000 | 103,795,000 | 103,721,000 | 103,685 | 103,723,000 | ||||||||||||||||||||||||||||||||
| february 2025 notes | 49,522 | 49,493,000 | 49,465,000 | 49,442,000 | ||||||||||||||||||||||||||||||||||
| april 2025 notes | 73,351 | |||||||||||||||||||||||||||||||||||||
| june 2025 notes | 69,272 | 69,233,000 | 69,217,000 | |||||||||||||||||||||||||||||||||||
| march 2026 a notes | 49,550 | |||||||||||||||||||||||||||||||||||||
| 2033 notes | 38,610 | 38,582,000 | 38,555,000 | 38,528,000 | 38,501 | 38,474,000 | 38,447,000 | 38,420,000 | 38,427,000 | 38,752,000 | ||||||||||||||||||||||||||||
| 2022 convertible notes | 228,177 | 227,786,000 | 227,395,000 | 227,004,000 | 226,614 | 226,223,000 | 225,832,000 | 225,441,000 | 225,051,000 | 224,660,000 | 224,269,000 | 223,878,000 | ||||||||||||||||||||||||||
| credit facilities | 37,492,000 | 71,125,000 | 103,919 | 11,585,000 | 93,421,000 | 44,266,000 | 52,956,000 | 80,894,000 | 58,323,000 | 5,016 | ||||||||||||||||||||||||||||
| investments: | ||||||||||||||||||||||||||||||||||||||
| total investments in securities, at value | 2,420,827,000 | 2,363,521,000 | 2,302,480,000 | 2,314,526 | 2,247,206,000 | 2,251,999,000 | 2,081,042,000 | 1,880,373,000 | 1,760,516,000 | 1,701,936,000 | 1,483,578,000 | 1,542,214 | 1,417,114,000 | |||||||||||||||||||||||||
| 2025 notes | 73,256,000 | 73,161,000 | 73,066,000 | 72,970 | 72,875,000 | 72,780,000 | 72,685,000 | 72,590,000 | 72,495,000 | 72,616,000 | ||||||||||||||||||||||||||||
| 2024 notes | 81,852,000 | 81,791,000 | 81,694,000 | 179,161,000 | 179,001 | 251,716,000 | 251,478,000 | 251,240,000 | 245,490 | 237,663,000 | 237,570,000 | 100,211,000 | 103,000 | 103,000,000 | 103,000,000 | 103,000,000 | 103,000 | 103,000,000 | ||||||||||||||||||||
| treasury stock | -4,062,000 | |||||||||||||||||||||||||||||||||||||
| 2021 asset-backed notes | 3,423,000 | 30,698,000 | 33,156,000 | 48,650 | 64,860,000 | 86,865,000 | 100,388,000 | 107,972 | 115,531,000 | 127,461,000 | 127,227,000 | 129,300 | 129,300,000 | 129,300,000 | 129,300,000 | 129,300 | ||||||||||||||||||||||
| unrealized appreciation (depreciation) on investments | -53,784,000 | -56,760,000 | -17,076 | -14,706,000 | -5,224,000 | -25,141,000 | -10,288,000 | -37,922,000 | ||||||||||||||||||||||||||||||
| accumulated undistributed realized gains on investments | -30,855,000 | -34,205,000 | -25,294,000 | -20,374 | 10,674,000 | 35,128,000 | 40,840,000 | 37,603 | ||||||||||||||||||||||||||||||
| undistributed net investment income | 27,848,000 | 28,255,000 | 32,159,000 | 32,515 | -12,642,000 | -10,368 | -7,311,000 | -8,429,000 | -2,710,000 | 4,563 | 2,361,000 | 3,293,000 | ||||||||||||||||||||||||||
| unrealized depreciation on investments | -94,957,000 | -79,760 | -73,388,000 | -106,941,000 | -120,528,000 | -89,025 | -68,880,000 | -68,046,000 | -54,142,000 | -52,808 | -50,118,000 | -24,238,000 | -11,462,000 | -23,390,000 | -20,405,000 | |||||||||||||||||||||||
| convertible notes | 223,488 | 223,097,000 | 222,898,000 | 222,542,000 | ||||||||||||||||||||||||||||||||||
| 2019 notes | 108,818 | 108,659,000 | 108,499,000 | 108,339,000 | 110,364 | 150,364,000 | 150,364,000 | 170,364,000 | 170,364 | 170,364,000 | 170,364,000 | |||||||||||||||||||||||||||
| distributions in excess of net investment income | -5,443,000 | -3,749,000 | -3,360,000 | -371 | -11,549,000 | -12,123,000 | ||||||||||||||||||||||||||||||||
| total investments, at value | 1,395,469,000 | 1,406,267,000 | 1,423,942 | 1,320,610,000 | 1,302,778,000 | 1,291,310,000 | 1,200,638 | 1,151,728,000 | 1,238,655,000 | 1,161,421,000 | 1,020,737 | 998,913,000 | 991,345,000 | 445,054,000 | 431,521,000 | 379,973,000 | 414,847,000 | 452,390,000 | ||||||||||||||||||||
| long-term sba debentures | 187,501 | 187,333,000 | 187,165,000 | 186,997,000 | 190,200 | 190,200,000 | 190,200,000 | 190,200,000 | 190,200 | 190,200,000 | 190,200,000 | 163,750,000 | 137,100,000 | 130,600,000 | 130,600,000 | 130,600,000 | ||||||||||||||||||||||
| long-term liabilities | 17,572,000 | 17,522 | 17,461,000 | 17,399,000 | 17,375,000 | 17,345 | 40,012,000 | 73,060,000 | ||||||||||||||||||||||||||||||
| wells facility | 61,003,000 | 50,000 | 49,622,000 | |||||||||||||||||||||||||||||||||||
| accumulated realized gains on investments | 31,420,000 | 23,550,000 | 23,525,000 | 27,993 | 22,503,000 | 16,137,000 | 17,391,000 | 14,079 | -24,408,000 | -27,767,000 | -1,426,000 | |||||||||||||||||||||||||||
| non-control/non-affiliate investments: | ||||||||||||||||||||||||||||||||||||||
| debt investments | 1,204,136,000 | 1,109,196 | ||||||||||||||||||||||||||||||||||||
| equity investments | 55,837,000 | 60,781 | ||||||||||||||||||||||||||||||||||||
| warrant investments | 23,240,000 | 22,675 | ||||||||||||||||||||||||||||||||||||
| total non-control/non-affiliate investments | 1,283,213,000 | 1,192,652 | ||||||||||||||||||||||||||||||||||||
| affiliate investments: | ||||||||||||||||||||||||||||||||||||||
| total affiliate investments | 8,097,000 | 7,986 | ||||||||||||||||||||||||||||||||||||
| non-control/non affiliate investments: | ||||||||||||||||||||||||||||||||||||||
| 2017 asset-backed notes | 4,203,000 | 16,049 | ||||||||||||||||||||||||||||||||||||
| amounts includes 1.9 million in net unrealized depreciation on investments, other assets, and accrued liabilities including escrow receivables, estimated taxes payable, and citigroup warrant participation agreement liabilities. | ||||||||||||||||||||||||||||||||||||||
| asset-backed notes | 133,503,000 | 27,951,000 | 46,547,000 | |||||||||||||||||||||||||||||||||||
| accumulated realized losses on investments | -2,233,000 | -7,897,000 | -46,663,000 | |||||||||||||||||||||||||||||||||||
| net assets: | ||||||||||||||||||||||||||||||||||||||
| distributions in excess of investment income | -5,742,000 | -6,306,000 | -5,917,000 | -4,041,000 | -3,754,000 | |||||||||||||||||||||||||||||||||
| portfolio company | ||||||||||||||||||||||||||||||||||||||
| acceleron pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| total acceleron pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| anthera pharmaceuticals inc. | ||||||||||||||||||||||||||||||||||||||
| total anthera pharmaceuticals inc. | ||||||||||||||||||||||||||||||||||||||
| aveo pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| total aveo pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| dicerna pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| total dicerna pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| epicept corporation | ||||||||||||||||||||||||||||||||||||||
| total epicept corporation | ||||||||||||||||||||||||||||||||||||||
| horizon therapeutics, inc. | ||||||||||||||||||||||||||||||||||||||
| total horizon therapeutics, inc. | ||||||||||||||||||||||||||||||||||||||
| inotek pharmaceuticals corp. | ||||||||||||||||||||||||||||||||||||||
| total inotek pharmaceuticals corp. | ||||||||||||||||||||||||||||||||||||||
| merrimack pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| total merrimack pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| paratek pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| total paratek pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| deferred loan origination revenue | -4,893,000 | -3,210,000 | -3,207,000 | -4,274,000 | ||||||||||||||||||||||||||||||||||
| net assets | 352,683,000 | 366,412,000 | 368,722,000 | 364,233,000 | ||||||||||||||||||||||||||||||||||
| elixir pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| total elixir pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| epicept corporation. | ||||||||||||||||||||||||||||||||||||||
| total epicept corporation. | ||||||||||||||||||||||||||||||||||||||
| short-term credit facility | ||||||||||||||||||||||||||||||||||||||
| non-affiliate investments | 410,567,000 | 451,257,000 | ||||||||||||||||||||||||||||||||||||
| accumulated realized gain on investments | -15,600,000 | |||||||||||||||||||||||||||||||||||||
| portola pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| total portola pharmaceuticals, inc. | ||||||||||||||||||||||||||||||||||||||
| recoly, n.v. | ||||||||||||||||||||||||||||||||||||||
| total recoly, n.v. | ||||||||||||||||||||||||||||||||||||||
| total drug discovery | ||||||||||||||||||||||||||||||||||||||
| long-term credit facility | 417,000 | |||||||||||||||||||||||||||||||||||||
| acceleron pharmaceuticals, inc.* | ||||||||||||||||||||||||||||||||||||||
| affinity videonet, inc. | ||||||||||||||||||||||||||||||||||||||
| total affinity videonet, inc. |
We provide you with 20 years of balance sheets for Hercules Capital stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Hercules Capital. Explore the full financial landscape of Hercules Capital stock with our expertly curated balance sheets.
The information provided in this report about Hercules Capital stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.